Novel peptides derived from neuropeptide Y prevent chemotherapy-induced bone marrow damage by regulating hematopoietic stem cell microenvironment

Chemotherapy-induced bone marrow damage is accompanied by acute nerve injury in the bone marrow (BM), resulting in sensory and autonomic neuropathy. Cisplatin, a popular chemotherapy drugs, induces the impairment of hematopoietic stem cells (HSCs) and bone marrow regeneration, leading to chronic bon...

Full description

Bibliographic Details
Main Authors: Min Hee Park, Bosung Baek, Hee Kyung Jin, Jae-sung Bae
Format: Article
Language:English
Published: Taylor & Francis Group 2018-09-01
Series:Animal Cells and Systems
Subjects:
Online Access:http://dx.doi.org/10.1080/19768354.2018.1517826
_version_ 1828240021213151232
author Min Hee Park
Bosung Baek
Hee Kyung Jin
Jae-sung Bae
author_facet Min Hee Park
Bosung Baek
Hee Kyung Jin
Jae-sung Bae
author_sort Min Hee Park
collection DOAJ
description Chemotherapy-induced bone marrow damage is accompanied by acute nerve injury in the bone marrow (BM), resulting in sensory and autonomic neuropathy. Cisplatin, a popular chemotherapy drugs, induces the impairment of hematopoietic stem cells (HSCs) and bone marrow regeneration, leading to chronic bone marrow abnormalities. Previously, we reported the protective roles of neuropeptide Y (NPY) against cisplatin-induced bone marrow impairment. In this study, we identified novel peptides, generated from full-length NPY that rescued cisplatin-induced sensory neuropathy and HSC suppression by regulating cell survival in the BM microenvironment. One of these peptides, especially, showed a better protective property against these impairments compared to that seen in full-length NPY. Therefore, we suggest the NPY sequences most effective against the chemotherapy-induced bone marrow dysfunction that could be potentially useful as therapeutic agents for patients receiving chemotherapy.
first_indexed 2024-04-12T21:34:02Z
format Article
id doaj.art-eb3d3f22ce0f4b6e9fda74f835a134a8
institution Directory Open Access Journal
issn 1976-8354
2151-2485
language English
last_indexed 2024-04-12T21:34:02Z
publishDate 2018-09-01
publisher Taylor & Francis Group
record_format Article
series Animal Cells and Systems
spelling doaj.art-eb3d3f22ce0f4b6e9fda74f835a134a82022-12-22T03:15:58ZengTaylor & Francis GroupAnimal Cells and Systems1976-83542151-24852018-09-0122528128810.1080/19768354.2018.15178261517826Novel peptides derived from neuropeptide Y prevent chemotherapy-induced bone marrow damage by regulating hematopoietic stem cell microenvironmentMin Hee Park0Bosung Baek1Hee Kyung Jin2Jae-sung Bae3Kyungpook National UniversityKyungpook National UniversityKyungpook National UniversityKyungpook National UniversityChemotherapy-induced bone marrow damage is accompanied by acute nerve injury in the bone marrow (BM), resulting in sensory and autonomic neuropathy. Cisplatin, a popular chemotherapy drugs, induces the impairment of hematopoietic stem cells (HSCs) and bone marrow regeneration, leading to chronic bone marrow abnormalities. Previously, we reported the protective roles of neuropeptide Y (NPY) against cisplatin-induced bone marrow impairment. In this study, we identified novel peptides, generated from full-length NPY that rescued cisplatin-induced sensory neuropathy and HSC suppression by regulating cell survival in the BM microenvironment. One of these peptides, especially, showed a better protective property against these impairments compared to that seen in full-length NPY. Therefore, we suggest the NPY sequences most effective against the chemotherapy-induced bone marrow dysfunction that could be potentially useful as therapeutic agents for patients receiving chemotherapy.http://dx.doi.org/10.1080/19768354.2018.1517826Bone marrow damagebone marrow microenvironment cellsChemotherapyhematopoietic stem cellneuropeptide Y-derived recombinant peptides
spellingShingle Min Hee Park
Bosung Baek
Hee Kyung Jin
Jae-sung Bae
Novel peptides derived from neuropeptide Y prevent chemotherapy-induced bone marrow damage by regulating hematopoietic stem cell microenvironment
Animal Cells and Systems
Bone marrow damage
bone marrow microenvironment cells
Chemotherapy
hematopoietic stem cell
neuropeptide Y-derived recombinant peptides
title Novel peptides derived from neuropeptide Y prevent chemotherapy-induced bone marrow damage by regulating hematopoietic stem cell microenvironment
title_full Novel peptides derived from neuropeptide Y prevent chemotherapy-induced bone marrow damage by regulating hematopoietic stem cell microenvironment
title_fullStr Novel peptides derived from neuropeptide Y prevent chemotherapy-induced bone marrow damage by regulating hematopoietic stem cell microenvironment
title_full_unstemmed Novel peptides derived from neuropeptide Y prevent chemotherapy-induced bone marrow damage by regulating hematopoietic stem cell microenvironment
title_short Novel peptides derived from neuropeptide Y prevent chemotherapy-induced bone marrow damage by regulating hematopoietic stem cell microenvironment
title_sort novel peptides derived from neuropeptide y prevent chemotherapy induced bone marrow damage by regulating hematopoietic stem cell microenvironment
topic Bone marrow damage
bone marrow microenvironment cells
Chemotherapy
hematopoietic stem cell
neuropeptide Y-derived recombinant peptides
url http://dx.doi.org/10.1080/19768354.2018.1517826
work_keys_str_mv AT minheepark novelpeptidesderivedfromneuropeptideypreventchemotherapyinducedbonemarrowdamagebyregulatinghematopoieticstemcellmicroenvironment
AT bosungbaek novelpeptidesderivedfromneuropeptideypreventchemotherapyinducedbonemarrowdamagebyregulatinghematopoieticstemcellmicroenvironment
AT heekyungjin novelpeptidesderivedfromneuropeptideypreventchemotherapyinducedbonemarrowdamagebyregulatinghematopoieticstemcellmicroenvironment
AT jaesungbae novelpeptidesderivedfromneuropeptideypreventchemotherapyinducedbonemarrowdamagebyregulatinghematopoieticstemcellmicroenvironment